37 million Americans have CKD, 90% unaware. Treatment focuses on managing underlying conditions and slowing disease progression
FDA-approved tablet for adults with type 2 diabetes-related chronic kidney disease. Used to slow kidney damage and reduce cardiovascular risks. Belongs to mineralocorticoid receptor antagonists class
Calculator estimates GFR based on serum creatinine, age, race, and gender. Available for both adults and children aged 18 and younger
Approved for type 2 diabetes treatment in patients aged 10 and older. Used alone or with metformin or linagliptin for glycemic control. Reduces cardiovascular death risk in patients with diabetes and cardiovascular disease. Approved for heart failure treatment in adults. Approved for chronic kidney disease treatment in adults
Dapagliflozin treats type 2 diabetes and heart failure. Developed by Bristol-Myers Squibb in partnership with AstraZeneca. Available as generic medication with multiple brand names. On WHO's List of Essential Medicines
Dialysis catheter contains two lumens: arterial (red) and venous (blue). Flow rates range between 200 and 500 ml/min. Most common type is Symmetrical-Tip catheter in spiral Z shape